JSM2025
Back to all people

Xiaowei Ren

Novo Nordisk US R&D
1 appearance in the program

Sessions & presentations

Statistical Innovation and Opportunities for Oncology Clinical Trials
Presentation: Quantifying Potential Bias Introduced by Imbalanced Disease Assessment Schedule in PFS Analysis
Contributed Papers · Mon, Aug 4 , 8:30 AM
First Author